Hamdan Bin Rashid Al Maktoum Foundation Advances Breast Cancer Care with Specialized Webinar

DUBAI: The Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences recently held a scientific webinar focused on the latest developments in breast cancer diagnosis and treatment, drawing participation from global experts and healthcare professionals. According to Emirates News Agency, the webinar successfully attracted a diverse group of attendees including healthcare professionals, researchers, and individuals engaged in oncology. The event provided a comprehensive overview of the most recent medical innovations and scientific breakthroughs in breast cancer, addressing ongoing challenges in bridging the gap between research and clinical practice. The discussion emphasized the complexity of breast cancer diagnosis, highlighting the need for advanced techniques such as molecular profiling and genetic testing. These methods enable the customization of treatment plans tailored to the individual characteristics of each patient, thereby enhancing the efficacy of the treatments administered. D r. Salama Al Muhairi, Director of Medical Excellence at the foundation, emphasized the organization's commitment to continuous medical education and raising awareness about the latest advancements in healthcare. "We aim to foster sustainable healthcare solutions and create opportunities for positive shifts in how the medical community approaches complex diseases like cancer," Dr. Al Muhairi stated. The webinar also featured insights from prominent figures in oncology, such as Prof. Melinda Telli from Stanford Cancer Institute, who discussed the latest advancements in targeted therapies for specific types of breast cancer. Additionally, Dr. Abeer Al Sayegh of the Sultan Qaboos Comprehensive Cancer Center elaborated on the role of genomics in enhancing patient care through personalized treatment solutions. Key topics covered included the importance of advanced imaging techniques like MRI and CT scans, which are crucial for accurately staging the disease and identifying tumor types. Despite these technological advancements, the integration of such tools into clinical practice remains inconsistent globally, indicating a significant gap between research and practical application. The session concluded with a series of recommendations aimed at enhancing collaboration among healthcare professionals and incorporating recent research findings into clinical settings to improve patient care and combat breast cancer more effectively.